Amrit Ray
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Amrit Ray currently works at Ultragenyx Pharmaceutical, Inc., as Independent Director from 2022, Everylife Foundation for Rare Diseases, as Director, CorEvitas LLC, as Director from 2021, Fortrea Holdings, Inc., as Lead Independent Director from 2025, and The Hastings Center, as Director.
Dr. Ray also formerly worked at Johnson & Johnson, as Chief Medical Officer, Pfizer Inc., as Global President-Research & Development from 2017 to 2021, and Biohaven Pharmaceuticals, Inc., as Chief Patient Officer in 2022.
Dr. Ray received his undergraduate degree and doctorate degree from The University of Edinburgh and Masters Business Admin degree from Tuck School of Business at Dartmouth.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FORTREA HOLDINGS INC. 0,06 % | 10.06.2026 | 52.453 ( 0,06 % ) | 807 252 $ | 31.05.2026 |
| 14.05.2026 | 31.116 ( 0,03 % ) | 744 917 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direktor/Vorstandsmitglied | 19.04.2022 |
| FORTREA HOLDINGS INC. | Direktor/Vorstandsmitglied | 29.06.2023 |
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology Operates as a science-led, real-world data intelligence company | Direktor/Vorstandsmitglied | 03.08.2021 |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Direktor/Vorstandsmitglied | - |
The Hastings Center
The Hastings Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization which address social and ethical challenges in medicine, healthcare, science and technology | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Corporate Officer/Principal | 01.12.2022 |
| PFIZER INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hastings Center
The Hastings Center Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization which address social and ethical challenges in medicine, healthcare, science and technology | Commercial Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Commercial Services |
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology Operates as a science-led, real-world data intelligence company | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
Fortrea Holdings, Inc.
Fortrea Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global contract research organization | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen